Back to SGMT
GOLDMAN SACHS GROUP INC → SGMT
GOLDMAN SACHS GROUP INC SGMT Position History
Sagimet Biosciences Inc. • Healthcare
Quarters held
9
Latest value
$564K
Q2 2026
Peak value
$5.3M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $77K |
| Q2 2025 | $142K |
| Q3 2025 | $104K |
| Q4 2025 | $746K |
| Q4 2025 | $746K |
| Q1 2026 | $790K |
| Q1 2026 | $95K |
| Q2 2026 | $5.3M |
| Q2 2026 | $564K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $564K | 73.0K | — | — |
| Q2 2026 | $5.3M | 686.1K | — | — |
| Q1 2026 | $95K | 18.1K | — | — |
| Q1 2026 | $790K | 151.1K | — | — |
| Q4 2025 | $746K | 125.9K | — | — |
| Q4 2025 | $746K | 125.9K | — | — |
| Q3 2025 | $104K | 15.2K | — | — |
| Q2 2025 | $142K | 18.6K | — | — |
| Q1 2025 | $77K | 23.6K | — | — |